The DOI matches its Crossref record; 172 of the 173 references it cites were found in a registry or an index, and 1 are not checked yet.
Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
Open accessAbstract
Alzheimer's disease (AD) is a major public health problem with substantial economic and social impacts around the world. The hallmarks of AD pathogenesis include deposition of amyloid β (Aβ), neurofibrillary tangles, and neuroinflammation. For many years, research has been focused on Aβ accumulation in senile plaques, as these aggregations were perceived as the main cause of the neurodegeneration found in AD. However, increasing evidence suggests that inflammation also plays a critical role in the pathogenesis of AD. Microglia cells are the resident macrophages of the brain and act as the first line of defense in the central nervous system. In AD, microglia play a dual role in disease progression, being essential for clearing Aβ deposits and releasing cytotoxic mediators. Aβ activates microglia through a variety of innate immune receptors expressed on these cells. The mechanisms through which amyloid deposits provoke an inflammatory response are not fully understood, but it is believed that these receptors cooperate in the recognition, internalization, and clearance of Aβ and in cell activation. In this review, we discuss the role of several receptors expressed on microglia in Aβ recognition, uptake, and signaling, and their implications for AD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FCγR activation also promotes Aβ clearance via phagocytosis [139, 140].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial LRP1 mediates Aβ uptake and activation of microglia (20–22).”
From LRPAP1 is released from activated microglia and inhibits microglial phagocytosis and amyloid beta aggregation (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Aβ fibrils also increase inflammation148 (Fig. 5, purple), which may unanchor residual PDE4A125, and further disinhibit stress signaling pathways.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [148]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mouse macrophages and COS cells, SHIP1 was shown to activate the ITIM of the inhibitory receptor FCγRIIβ, which inhibits the activating receptor FCγRIIA to block FCγRIIA-mediated phagocytosis (Fig. 3C).”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SHIP1 also was shown to directly inhibit FCγRIIA by binding to its ITAM (Fig. 3C), which prevents the activation of PI3K [134, 137–140].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
Delrieu, J., Ousset, P., Caillaud, C., & Vellas, B. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07458.x · Cited by 147
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Lemaître, B., Nicolas, E., Michaut, L., Reichhart, J., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,224
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Research works printed but not linked: 1
- 10.1146/annurev.bi.63.070194.003125 · DOI
Cited by
Sorted by citations
Items 101–200 of 349
Landlinger, C., Oberleitner, L., Gruber, P., Noiges, B., Yatsyk, K., Santic, R., Mandler, M., & Staffler, G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0369-6 · Cited by 60
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Dias, D., & Socodato, R. (2025) · Biomedicines · doi:10.3390/biomedicines13020279 · Cited by 60
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 63
Fernando, K., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Role of pattern recognition receptors of the neurovascular unit in inflamm-aging
Wilhelm, I., Nyúl-Tóth, Á., Kozma, M., Farkas, A. E., & Krizbai, I. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00106.2017 · Cited by 56
Interleukin-4 affects microglial autophagic flux
Tang, R.-H., Qi, R.-Q., & Liu, H.-Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255975 · Cited by 59
Chen, J., Yin, W. H., Tu, Y., Wang, S., Yang, X., Chen, Q., Zhang, X., Han, Y., & Pi, R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.025 · Cited by 53
Mesenchymal stromal cells for the treatment of Alzheimer’s disease: Strategies and limitations
Regmi, S., Liu, D. D., Shen, M., Kevadiya, B. D., Ganguly, A., Primavera, R., Chetty, S. S., Yarani, R., & Thakor, A. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1011225 · Cited by 53
Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans
Yang, C., Lin, S.-P., Chiang, C., Wu, Y., H’ng, W. S., Chang, C.-P., Chen, Y.-T., & Wu, J. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.12.012 · Cited by 52
Zhong, L., Jiang, X., Zhu, Z., Qin, H., Dinkins, M. B., Kong, J., Leanhart, S., Wang, R., Elsherbini, A. M., Bieberich, E., et al. (2018) · Glia · doi:10.1002/glia.23558 · Cited by 51
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
Sellés, M. C., Oliveira, M. M., & Ferreira, S. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179925 · Cited by 51
Neuroinflammaging and the Immune Landscape: The Role of Autophagy and Senescence in Aging Brain
Tamatta, R., Pai, V., Jaiswal, C., Singh, I., & Singh, A. K. (2025) · Biogerontology · doi:10.1007/s10522-025-10199-x · Cited by 53
Xing, H., Guo, S., Zhang, Y., Zheng, Z., & Wang, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5369 · Cited by 49
Doens, D., Valiente, P. A., Mfuh, A. M., Vo, A. X. T., Tristan, A., Carreño, L., Quijada, M. R., Nguyen, V. T., Perry, G. L., Larionov, O. V., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00386 · Cited by 49
Self-citationFołta, J., Rzepka, Z., & Wrześniok, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115177 · Cited by 50
Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer’s disease mice
Torika, N., Asraf, K., Cohen, H., & Fleisher‐Berkovich, S. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.001 · Cited by 47
Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
Asraf, K., Torika, N., Apte, R. N., & Fleisher‐Berkovich, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00116 · Cited by 49
Adams, S. L., Tilton, K., Kozubek, J. A., Seshadri, S., & Delalle, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw056 · Cited by 45
Chandran, S., & Binninger, D. (2023) · Antioxidants · doi:10.3390/antiox13010021 · Cited by 45
Abbas, K., Mustafa, M., Alam, M., Habib, S., Ahmad, W., Adnan, M., Hassan, M. I., & Usmani, N. (2025) · Neurogenetics · doi:10.1007/s10048-025-00821-y · Cited by 48
Thygesen, C., Ilkjær, L., Kempf, S. J., Hemdrup, A. L., von Linstow, C. U., Babcock, A. A., Darvesh, S., Larsen, M. R., & Finsen, B. R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00397 · Cited by 44
Lin, M.-H., Cheng, P.-C., Hsiao, P.-J., Chen, S.-C., Hung, C.-H., Kuo, C.-H., Huang, S.-K., & Clair Chiou, H.-Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109653 · Cited by 42
Page, A. Y. L., Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., & Fülöp, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170124 · Cited by 42
Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 42
Herrera-Rivero, M., Santarelli, F., Brosseron, F., Kummer, M. P., & Heneka, M. T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1540-3 · Cited by 44
Fiala, M., Terrando, N., & Dalli, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150367 · Cited by 43
Welcome, M. O. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100176 · Cited by 41
Yang, S., Magnutzki, A., Alami, N. O., Lattke, M., Hein, T. M., Scheller, J. S., Kröger, C., Oswald, F., Yilmazer‐Hanke, D., Wirth, T., et al. (2021) · Cells · doi:10.3390/cells10102669 · Cited by 42
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 41
Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function
Alaei, M., Koushki, K., Taebi, K., Taba, M. Y., Hedayati, S. K., & Shahbaz, S. K. (2025) · RSC Advances · doi:10.1039/d4ra07798a · Cited by 42
Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases
Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 40
Immunotherapies in Alzheimer’s disease: Too much, too little, too late or off-target?
St‐Amour, I., Cicchetti, F., & Calon, F. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1518-9 · Cited by 40
FTO: An Emerging Molecular Player in Neuropsychiatric Diseases
Annapoorna, P. K., Iyer, H., Parnaik, T., Narasimhan, H., Bhattacharya, A., & Kumar, A. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.021 · Cited by 40
The Vascular-Immune Hypothesis of Alzheimer’s Disease
Mehta, R. I., & Mehta, R. I. (2023) · Biomedicines · doi:10.3390/biomedicines11020408 · Cited by 39
Microglia degrade Alzheimer’s amyloid-beta deposits extracellularly via digestive exophagy
Jacquet, R. G., González Ibáñez, F., Picard, K., Funes, L., Khakpour, M., Gouras, G. K., Tremblay, M.-È., Maxfield, F. R., & Solé-Domènech, S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115052 · Cited by 42
Azrad, M., Zeineh, N., Weizman, A., Veenman, L., & Gavish, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030594 · Cited by 37
Amyloid Proteins and Peripheral Neuropathy
Albariqi, M. M. H., Engelsman, S., Eijkelkamp, N., & Höppener, J. W. M. (2020) · Cells · doi:10.3390/cells9061553 · Cited by 41
Simone, A. D., Naldi, M., Tedesco, D., Milelli, A., Bartolini, M., Davani, L., Widera, D., Dallas, M. L., & Andrisano, V. (2019) · ACS Omega · doi:10.1021/acsomega.9b01531 · Cited by 37
Structural elucidation and anti-neuroinflammatory activity of Polygala tenuifolia polysaccharide
Zeng, Z., Chang, X., Zhang, D., Chen, H., Zhong, X., Xie, Y., Yu, Q., & Yan, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.161 · Cited by 37
Taming microglia: the promise of engineered microglia in treating neurological diseases
Luo, E. Y., & Sugimura, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03015-9 · Cited by 35
Lipid droplet accumulation in microglia and their potential roles
Li, Y., Zhao, Q., Wang, Y., Du, W., Yang, R., Wu, J., & Li, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02633-3 · Cited by 39
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
Merlo, S., Spampinato, S. F., Caruso, G. I., & Sortino, M. A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200131105418 · Cited by 35
Microglial cell response to experimental periodontal disease
Almarhoumi, R., Álvarez, C., Harris, T., Tognoni, C. M., Paster, B. J., Carreras, I., Dedeoglu, A., & Kantarcı, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02821-x · Cited by 36
Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36
Hubin, E., Deroo, S., Schierle, G. S. K., Kaminski, C. F., Serpell, L. C., Subramaniam, V., van Nuland, N. A. J., Broersen, K., Raussens, V., & Sarroukh, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1983-2 · Cited by 36
Iwahara, N., Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160887 · Cited by 34
Esculentoside A suppresses Aβ1–42-induced neuroinflammation by down-regulating MAPKs pathwaysin vivo
Yang, H., Wang, S., Yu, L., Zhu, X., & Xu, Y. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000066 · Cited by 33
Li, Z., Zhao, T., Shi, M., Wei, Y., Huang, X., Shen, J., Zhang, X., Xie, Z., Huang, P., Yuan, K., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1139558 · Cited by 33
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 33
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 33
Jairani, P. S., Mallika, A. P., Krishnan, D., Menon, R. N., Verghese, J., Mathuranath, P. S., & Gopala, S. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00651-1 · Cited by 32
An, X.-Q., Xi, W., Gu, C.-Y., & Huang, X. (2018) · médecine/sciences · doi:10.1051/medsci/201834f120 · Cited by 31
Glimepiride reduces CD14 expression and cytokine secretion from macrophages
Ingham, V. A., Williams, A., & Bate, C. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-115 · Cited by 31
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 30
Yavari, M., Kalupahana, N. S., Harris, B. N., Ramalingam, L., Zu, Y., Kahathuduwa, C. N., & Moustaïd‐Moussa, N. (2025) · Nutrients · doi:10.3390/nu17071203 · Cited by 29
NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines
Wang, X., Yin, Z., Cao, P., Zheng, S., Chen, Y., Yu, M., Liao, C., Zhang, Z., Duan, Y., Han, J., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110964 · Cited by 29
Neuroimmune disruptions from naturally occurring levels of mycotoxins
Shahba, S., Mehrzad, J., & Malvandi, A. M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14146-4 · Cited by 29
Shared pathophysiology: Understanding stroke and Alzheimer’s disease
Sriram, S., Mehkri, Y., Quintin, S. S., & Lucke-Wold, B. P. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107306 · Cited by 29
Wątroba, M., & Szukiewicz, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.962769 · Cited by 29
Lv, J., Wang, W., Zhu, X., Xu, X., Yan, Q., Lu, J., Shi, X., Wang, Z., Zhou, J., Huang, X., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.041 · Cited by 28
Li, J., Zhong, J., Chen, H., Yu, Q., & Yan, C. (2020) · Industrial Crops and Products · doi:10.1016/j.indcrop.2020.112792 · Cited by 28
Snapshot of microglial physiological functions
Verkhratsky, A., Sun, D., & Tanaka, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104960 · Cited by 28
Lorenzi, E. D., Franceschini, D., Contardi, C., Martino, R. M. C. D., Seghetti, F., Serra, M., Bisceglia, F., Pagetta, A., Zusso, M., & Belluti, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084381 · Cited by 28
Duggal, P., & Mehan, S. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190125 · Cited by 28
Ge, T.-Q., Guan, P.-P., & Wang, P. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105868 · Cited by 28
Ren, J., Wang, Q., Hong, H., & Tang, C. (2025) · Microorganisms · doi:10.3390/microorganisms13081956 · Cited by 28
Dong, Z., Li, J., Gan, Y., Sun, X., Leng, Y., & Ge, J. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.05.06 · Cited by 27
Culibrk, R. A., & Hahn, M. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.583884 · Cited by 28
Is carbonyl/AGE/RAGE stress a hallmark of the brain aging?
Semchyshyn, H. M. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02529-y · Cited by 27
Li, Q., Rubin, L., Silva, M., Li, S., Yang, C., Lazarovici, P., & Zheng, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3777021 · Cited by 28
Fraga, V. G., Ferriani, M. D. G. C., Caramelli, P., Sousa, L. P., & Gomes, K. B. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.005 · Cited by 26
Chernyaeva, L., Ratti, G., Teirilä, L., Fudo, S., Rankka, U., Pelkonen, A., Korhonen, P., Leskinen, K., Keskitalo, S., Salokas, K., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256467 · Cited by 29
The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer’s disease
Brock, A. J., Kasus‐Jacobi, A., Lerner, M. R., Logan, S., Adesina, A. M., & Pereira, H. A. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1347-x · Cited by 26
Intracellular trafficking of TREM2 is regulated by presenilin 1
Zhao, Y., Li, X., Huang, T. Y., Jiang, L.-L., Tan, Z., Zhang, M., Cheng, I. H.-J., Wang, X., Bu, G., Zhang, Y., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.200 · Cited by 26
Piccarducci, R., Pietrobono, D., Pellegrini, C., Daniele, S., Fornai, M., Antonioli, L., Trincavelli, M. L., Blandizzi, C., & Martini, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5030475 · Cited by 26
Panayiotou, E., Fella, E., Andreou, S., Papacharalambous, R., Gerasimou, P., Costeas, P., Angeli, S., Kousiappa, I., Papacostas, S., & Kyriakides, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225417 · Cited by 26
Jang, S. K., Yu, J. M., Kim, S. T., Kim, G. H., Park, D. W., Lee, D. I., & Joo, S. S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.071 · Cited by 26
Biological agents and the aging brain: glial inflammation and neurotoxic signaling
Latham, A. S., Moreno, J. A., & Geer, C. E. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1244149 · Cited by 27
Lana, D., Traini, C., Bulli, I., Sarti, G., Magni, G., Attorre, S., Giovannini, M. G., & Vannucchi, M. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451114 · Cited by 27
Pike, A. F., Kramer, N. I., Blaauboer, B. J., Seinen, W., & Brands, R. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.006 · Cited by 26
Lee, E. H.-C., Lim, S. S.-C., Yuen, K.-H., & Lee, C. Y. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13052 · Cited by 25
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
Perea, J. R., Bolós, M., Cuadros, R., García, E., García‐Escudero, V., Hernández, F., McManus, R. M., Heneka, M. T., & Ávila, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02715-0 · Cited by 24
Cleland, N. R. W., & Bruce, K. D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.012 · Cited by 23
Brain resident microglia in Alzheimer’s disease: foe or friends
Kaur, S., Malleshwari, K., Sharma, A., Giridharan, V. V., & Dandekar, M. P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01550-8 · Cited by 23
Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
Dar, K. B., Bhat, A. H., Amin, S., Reshi, B. A., Zargar, M. A., Masood, A., & Ganie, S. A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00741-0 · Cited by 23
Han, Y., Zhu, X., Xie, J., Zhao, Y., & Liu, X. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.010 · Cited by 23
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 23
Basha, S. C., Ramaiah, M. J., & Rao, K. S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221070 · Cited by 23
Kumar, M., & Bansal, N. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1524-2 · Cited by 22
Chavoshinezhad, S., Kouchesfahani, H. M., Salehi, M. S., Pandamooz, S., Ahmadiani, A., & Dargahi, L. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.06.015 · Cited by 23
Zarini-Gakiye, E., Amini, J., Sanadgol, N., Vaezi, G., & Kazem, P. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200422090135 · Cited by 22
Metabolic factors in the regulation of hypothalamic innate immune responses in obesity
Folick, A., Cheang, R. T., Valdearcos, M., & Koliwad, S. K. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00666-z · Cited by 26
Tangeretin Inhibits BACE1 Activity and Attenuates Cognitive Impairments in AD Model Mice
Bao, J., Liang, Z., Gong, X., Zhao, Y., Wu, M., Liu, W., Tu, C., Wang, X., & Shu, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07241 · Cited by 21
Meng, M., Di, A. I., Sun, L., Xu, X., & Cao, X. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001223 · Cited by 21
van Rees, G. F., Lago, S. G., Cox, D., Tomasik, J., Rustogi, N., Weigelt, K., Özcan, S., Cooper, J. D., Drexhage, H. A., Leweke, F. M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.003 · Cited by 22
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Ayyubova, G., & Fazal, N. (2024) · Brain Sciences · doi:10.3390/brainsci14050434 · Cited by 20
cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities
Fazal, F., Dar, N. J., Ahamad, S., Khan, S., Bano, N., Saha, S., Nazir, A., & Bhat, S. A. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101444 · Cited by 21
Metadata
- Authors
- Doens, D., & Fernández, P. L.
- Affiliations
- Acharya Nagarjuna University (IN)
- Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (PA)
- Corresponding author
- Fernández, Patricia L
- Venue
- Journal of Neuroinflammation
- Published
- 2014
- Volume
- 11
- Issue
- 1
- Pages
- 48
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC3975152
- OpenAlex
- W2100011299
- Cited by
- 348
- References
- 172
- Citations by year
- 2026: 22 · 2025: 42 · 2024: 33 · 2023: 33 · 2022: 36 · 2021: 27 · 2020: 24 · 2019: 24 · 2018: 27 · 2017: 26 · 2016: 24 · 2015: 25 · 2014: 5
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Greater South Information System
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, microglia, innate immune receptors, neuroinflammation, amyloid clearance, receptor signaling, microglial activation, amyloid plaques, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Receptors, Immunologic, Amyloid beta-Peptides, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review